# MediCare Phase 13 Completion Report

**Author:** Manus AI  
**Phase:** 13 — AI Requirements, Dataset & Algorithm Specification  
**Status:** **Complete — BLOCKED outcome documented**  
**Source of truth:** The authoritative `pasted_content_14.txt` prompt, the current Phase 1–12 MediCare implementation, the supplied SRS/project documentation, and prior phase reports.  
**Validation environment:** Isolated Ubuntu sandbox using the existing local test configuration. Windows PostgreSQL was not accessed.

> **Final outcome:** **BLOCKED.** No first AI capability, target, approved dataset, or final algorithm is sufficiently defined to proceed safely to model implementation. No model was trained and Phase 14 was not started.

## 1. Phase status

Phase 13 is complete as a specification and decision phase. It resolves the previous Phase 12 blocker by documenting precisely why the project cannot yet select or implement one AI capability: the source material identifies broad candidate areas but does not provide a single problem definition, feature schema, target variable, approved dataset/corpus, or final algorithm.

The phase created and updated specification documents only. It did not train a model, create an artifact, expose an endpoint, modify the database, connect the frontend, or alter the UI/UX.

## 2. AI requirements reviewed

The reviewed requirements identify symptom analysis, disease/risk prediction, medical-report analysis, medicine information, drug interaction, health recommendations, explainable AI, medical knowledge retrieval/RAG, chatbot functionality, privacy, auditability, safety, human oversight, and future model evaluation.

The original project material is aspirational in several areas. The former symptom checker was a deterministic frontend demonstration, and Phase 10 intentionally converted it into a safe deferred state rather than treating it as a production model.

## 3. Candidate AI capabilities

| Capability | Current evidence | Current status |
|---|---|---|
| Symptom analysis | Former AI Insights interaction; no persistent symptom schema or approved target | BLOCKED |
| Disease/risk prediction | Broad SRS/marketing requirement; no cohort, label, horizon, or features | BLOCKED |
| Medical-report analysis | Existing report models; no task definition, units, annotation set, or corpus | BLOCKED |
| Medicine information | Broad SRS/marketing requirement; no normalized medicine vocabulary or licensed source | BLOCKED |
| Drug interaction | Broad SRS/marketing requirement; no normalized medicines or authoritative interaction source | BLOCKED |
| Health recommendations | Broad SRS/marketing requirement; no clinician policy, consent, or escalation design | BLOCKED |
| Chatbot/RAG | Future architecture only; no corpus, provider, intent policy, or provenance contract | DEFERRED |

Full analysis is in `docs/AI_CAPABILITY_INVENTORY.md`.

## 4. Selected first AI capability

**None selected.** The final first-capability decision is **BLOCKED**.

Symptom analysis is the most visibly shaped candidate because the existing frontend once contained a symptom-entry workflow. However, that workflow was explicitly a deterministic demonstration, was disabled as a source of medical claims in Phase 10, and does not define a production target, labeled dataset, clinical threshold, or evaluation protocol. Selecting it solely because it has a visible UI would invent requirements.

## 5. Selection reasoning

No candidate meets all Phase 13 selection criteria simultaneously: explicit requirement support, available data, technical feasibility, safety, architecture compatibility, evaluability, and reasonable academic scope. Disease prediction requires outcome labels and a cohort; report analysis requires a structured annotation task or approved corpus; medicine and interaction features require authoritative licensed knowledge; recommendations require clinician-reviewed policy and consent; chatbot/RAG is already deferred.

The compliant selection is therefore **BLOCKED**, not an arbitrary algorithm or capability.

## 6. Problem definition

No final problem definition exists. Before model work, the owner must specify one exact problem statement, unit of prediction, task type, intended user, intended use, prohibited use, input boundary, output/abstention behavior, and human escalation path.

## 7. AI task type

No task type is selected. Candidate types include classification for symptoms/risk, extraction or bounded explanation for reports, retrieval for medicine information/interactions, and policy-based educational information. The supplied requirements do not justify choosing among them.

## 8. Input definition

No final input contract is approved. The current application exposes profiles, appointments, medical records, prescriptions, reports, findings, and preferences, but availability does not make a field appropriate for AI use. Future inputs must be minimal, typed, validated, authorized, privacy-reviewed, and tied to one approved task.

## 9. Feature schema

`ai/preprocessing/FEATURE_SCHEMA.md` records the conditional feature boundary. Candidate fields include structured record/report types and dates, standardized report findings, normalized medicine identifiers, and explicitly approved symptom fields if they are later added.

Names, email addresses, phone numbers, addresses, license IDs, and other direct identifiers are excluded by default. Age, gender, and blood group are sensitive and cannot be used without a documented legitimate purpose and fairness review.

No feature schema is currently approved.

## 10. Target definition

**No target is defined.** The supplied requirements do not define a symptom label, disease outcome, prediction horizon, report annotation, interaction severity label, or recommendation policy. Label-generation method, clinical meaning, source, timestamp, and label-quality review are therefore missing.

Training is blocked until a target is approved.

## 11. Dataset requirements

`ai/datasets/DATASET_SPECIFICATION.md` defines the required dataset contract: named source, provenance, version/hash, license, schema, target, data quality, privacy/de-identification, authorization, retention, feature minimization, patient-level or temporal split, leakage prevention, imbalance handling, reproducibility, and approval.

The future dataset must be task-specific and must not contain unapproved real patient data.

## 12. Dataset availability

**Approved dataset unavailable.** Repository inspection found no candidate CSV, TSV, JSONL, Parquet, ARFF, Feather, or equivalent training dataset, no dataset version/hash, no target definition, no license record, and no training authorization.

The current Django clinical tables are operational application data, not an approved training dataset. No random public or Kaggle dataset was downloaded, no medical website was scraped, and no patient data was used.

## 13. Dataset provenance

Not applicable because no dataset was used. A future dataset must document origin, collection method, population, period, schema, transformations, version, and custodian.

## 14. Dataset licensing status

Not applicable because no dataset was selected. Public downloadability is not sufficient. A future source must have written permission for the intended academic training/evaluation/retention use.

## 15. Dataset privacy status

No dataset is present and no real patient data was introduced. Future use requires data minimization, de-identification or explicit authorization as appropriate, access controls, retention/deletion rules, auditability, and separation of training/test data.

## 16. Algorithm candidates

The candidate comparison includes Logistic Regression, Decision Tree, Random Forest, Gradient Boosting, SVM, and an approved NLP/retrieval approach. These are documented as conditional candidates only; none is selected.

## 17. Algorithm comparison

| Candidate | Potential fit | Main advantages | Main limitations and safety concerns |
|---|---|---|---|
| Logistic Regression | Defined binary/multiclass structured task | Simple, low compute, coefficient interpretation | Requires labels/encoded features; linear assumptions; calibration still required |
| Decision Tree | Small structured task | Path-level interpretability and modest compute | Overfitting/instability; can imply unsupported certainty |
| Random Forest | Nonlinear tabular classification | Robust baseline and moderate compute | Less transparent; probability calibration and feature-importance limitations |
| Gradient Boosting | Structured risk/classification | Potentially strong tabular performance | More tuning and overfitting risk; greater governance burden |
| SVM | Small high-dimensional task | Useful for some classification settings | Scaling/kernel/probability issues; lower clinical transparency |
| NLP/retrieval model | Report or medicine-information task | Handles text/reference retrieval when supported | Requires corpus/annotations/licensing/provenance and strong safety controls |

The comparison is not a model recommendation. Dataset and task characteristics are unknown.

## 18. Final algorithm selection

**None selected.** Algorithm status is **BLOCKED**.

## 19. Algorithm-selection reasoning

An algorithm cannot be selected responsibly until the problem type, feature schema, target, dataset characteristics, clinical operating point, evaluation protocol, and safety boundary are defined. `ai/algorithms/ALGORITHM_SELECTION.md` records the candidate comparison and explicit `BLOCKED` status.

## 20. Preprocessing requirements

Future preprocessing must validate task-specific types, choices, ranges, units, missingness, and ownership; fit imputation/encoding/scaling/feature selection only on training data; share the exact versioned transformation between training and inference; and reject impossible or unsupported clinical input.

No task-specific transformation is implemented in Phase 13. The Phase 11 generic contracts remain available but do not imply a selected model.

## 21. Training strategy

No training is performed. A future pipeline must use an approved versioned dataset, fit transformations only on training data, retain validation for model/configuration decisions, reserve a held-out test set, record seed/configuration/dependencies, and save a reviewed artifact without real patient data or secrets.

## 22. Test strategy

The future test strategy must use patient-level splitting when repeated observations could leak identity and temporal splitting when the model predicts future outcomes. Stratification may be used only when compatible with those constraints. Test data must not influence preprocessing, feature selection, threshold selection, or model choice.

No split is performed in Phase 13.

## 23. Evaluation metrics

`ai/models/EVALUATION_PLAN.md` specifies conditional metrics. Classification may use precision, recall, F1, confusion matrix, ROC-AUC where appropriate, sensitivity, specificity, calibration, and subgroup performance. Retrieval/lookup tasks may need evidence coverage, retrieval precision/recall, citation completeness, and severity-stratified recall.

All future metrics are **NOT YET EVALUATED**. No metric is fabricated in Phase 13.

## 24. Explainability plan

Future explanations must be appropriate to the selected model/task, identify relevant features or evidence, communicate limitations and uncertainty/abstention, and distinguish correlation from causation. Coefficients or paths may be considered for interpretable models; SHAP is not selected or installed.

No explainability is implemented or claimed.

## 25. Bias/fairness plan

`ai/models/BIAS_FAIRNESS_PLAN.md` addresses class imbalance, representation gaps, demographic bias, label bias, measurement bias, distribution shift, and proxy leakage. Future work must measure relevant subgroup sizes, performance, calibration, missingness, and error types without fabricating thresholds or fairness metrics.

Sensitive attributes are excluded by default and require a documented legitimate purpose, privacy review, and fairness rationale.

## 26. Safety requirements

The system remains **Clinical Decision Support / Informational Assistance**. It must not diagnose, prescribe, select medication dosage, modify treatment or records, order tests, approve/reject treatment, or replace a physician.

Future results require input/output validation, authorization, scope checks, abstention for unsupported or uncertain inputs, a disclaimer, provenance where relevant, qualified professional review, and escalation guidance for urgent or serious situations. `ai/safety/CLINICAL_SAFETY_PLAN.md` documents misuse and false-positive/negative risks.

## 27. Human oversight requirements

A qualified clinician must review any future clinical-support result before it influences care. The system must communicate uncertainty and limitations, allow escalation, and avoid converting output into an autonomous workflow. No Phase 13 frontend or API workflow is created.

## 28. Security requirements

Future AI work must enforce Django session authentication, role authorization, patient ownership, doctor appointment authorization, input/output validation, rate limiting considerations, minimal non-sensitive logging, secret management, external-provider restrictions, and safe error handling.

No patient data may be sent to an external AI service without explicit approval. No endpoint is exposed in Phase 13.

## 29. Model-versioning plan

Future versions must record model/algorithm version, dataset version, feature-schema version, preprocessing version, configuration version, training date, evaluation artifact, limitations, approval status, and rollback/retirement metadata. No model version or artifact exists now.

## 30. SRS traceability

`docs/AI_SRS_TRACEABILITY.md` maps every candidate requirement through problem definition, feature schema, target, dataset requirement, algorithm, and status. It uses only the Phase 13 vocabulary: `IMPLEMENTED`, `SPECIFIED`, `BLOCKED`, `DEFERRED`, and `NOT SPECIFIED`.

No model is marked implemented. Candidate clinical tasks are `BLOCKED`; RAG/chatbot are `DEFERRED`; architecture/governance plans are `SPECIFIED`.

## 31. Files created

| File | Purpose |
|---|---|
| `docs/AI_CAPABILITY_INVENTORY.md` | Candidate capability audit and first-capability decision |
| `docs/AI_REQUIREMENTS_SPECIFICATION.md` | Functional, non-functional, input/output, privacy, safety, and oversight requirements |
| `ai/preprocessing/FEATURE_SCHEMA.md` | Conditional feature-schema specification |
| `ai/datasets/DATASET_SPECIFICATION.md` | Required dataset contract and availability decision |
| `docs/AI_DATA_GOVERNANCE.md` | Ownership, provenance, licensing, privacy, retention, and approval rules |
| `ai/models/EVALUATION_PLAN.md` | Future metrics and train/validation/test strategy |
| `ai/models/BIAS_FAIRNESS_PLAN.md` | Bias and fairness risks and future analysis |
| `ai/safety/CLINICAL_SAFETY_PLAN.md` | Clinical safety, oversight, misuse, error, and escalation boundaries |
| `docs/PHASE13_NEXT_PHASE_REQUIREMENTS.md` | Exact entry criteria before model implementation |
| `PHASE13_COMPLETION_REPORT.md` | This report |

## 32. Files modified

| File | Change |
|---|---|
| `ai/algorithms/ALGORITHM_SELECTION.md` | Rewritten for Phase 13 candidate comparison and explicit `BLOCKED` status |
| `docs/AI_SRS_TRACEABILITY.md` | Rewritten with Phase 13 statuses and end-to-end traceability |
| `docs/AI_ROADMAP.md` | Updated to mark Phase 13 current/blocked and gate Phase 14 |

No application source, database, frontend, CSS, JavaScript, API, migration, or dependency file was modified.

## 33. Files intentionally unchanged

All Phase 1–12 application behavior remains unchanged: Django authentication, registration, logout, patient APIs, doctor APIs, appointment APIs, clinical APIs, permissions, models, migrations, URLs, requirements, all 12 frontend JavaScript files, all 11 frontend CSS files, all frontend HTML pages, the AI Insights deferred behavior, and the Phase 11 core AI interfaces.

Integrity comparisons against the Phase 12 package found 65 backend files, 12 frontend JavaScript files, 11 frontend HTML files, 11 CSS files, and `backend/requirements.txt` unchanged.

## 34. Database changes

**None.** Existing Django database models and data were not modified. No prediction, dataset, or AI audit table was created.

## 35. Frontend changes

**None.** No HTML, CSS, JavaScript, navigation, page structure, or UI/UX behavior was changed. AI remains disconnected from the frontend.

## 36. Dependency changes

**None.** No AI/ML, data-science, RAG, LLM, provider, vector, or external dependency was added. `backend/requirements.txt` remains unchanged.

## 37. Tests executed

The complete validation run executed:

| Test/check | Result |
|---|---|
| AI foundation and Phase 12 tests | 18/18 passed |
| Existing Django suite | 47/47 passed |
| Django system check | Passed; no issues |
| Migration check | Passed; no changes detected |
| Python compilation | Passed |
| JavaScript syntax | Passed for all 12 files |
| Frontend local references | 95/95 passed |
| Phase 13 document consistency | 11 required specification files present and consistent |
| Security/provider/artifact scans | Passed |
| Phase 12 integrity comparison | Backend/frontend/CSS/requirements unchanged |

## 38. Regression results

The existing 47-test Django suite passed with no regressions. All 18 AI foundation/blocked-path tests passed. No authentication, patient, doctor, appointment, clinical, frontend, or CSS source was changed.

## 39. Security-scan results

Scans found no external AI provider integration, active `/api/ai/` or `/api/chat/` endpoint, OpenAI/Google-style secret prefix, model artifact, dataset artifact, database password, or real patient dataset. No PostgreSQL connection was attempted.

## 40. Dataset status

**APPROVED DATASET NOT AVAILABLE.** No dataset is present, licensed, authorized, versioned, target-defined, or suitable for training. This is a critical blocker.

## 41. Algorithm status

**BLOCKED.** No final capability/problem/target/dataset is defined, so no final algorithm can be selected without invention.

## 42. Model status

**No model exists.** No training, artifact creation, prediction, confidence, metric measurement, or endpoint exposure occurred.

## 43. Remaining blockers

The critical blockers are one approved first capability, exact problem/task type, minimum feature schema, target/label-generation method, approved dataset or corpus, provenance/license/privacy/authorization, data split/leakage policy, algorithm selection, preprocessing version, evaluation metrics, fairness review, clinical safety boundary, and human oversight workflow.

## 44. Exact requirements for the next phase

Before model implementation, the owner must approve the capability, problem, features, target, dataset, algorithm, safety policy, and evaluation plan listed in `docs/PHASE13_NEXT_PHASE_REQUIREMENTS.md`. Phase 14 must not begin until those approvals are recorded. No model training, endpoint, frontend integration, external provider, or real data use is permitted as a substitute.

## 45. Final outcome

**BLOCKED.** The project is not ready for model implementation because critical requirements and the approved dataset are unavailable. This is the correct Phase 13 outcome under the authoritative prompt.

## Strict stop condition

Phase 13 is complete and stopped. No model was trained. No dataset was downloaded. No algorithm was invented. No endpoint, chatbot, RAG, LLM, external provider, database model, migration, or UI change was added. Phase 14 was not started.

## References

[1]: ../upload/pasted_content_14.txt "Authoritative Phase 13 requirements"
[2]: docs/AI_CAPABILITY_INVENTORY.md "Phase 13 candidate capability inventory"
[3]: docs/AI_REQUIREMENTS_SPECIFICATION.md "Phase 13 AI requirements specification"
[4]: ai/datasets/DATASET_SPECIFICATION.md "Phase 13 dataset specification"
[5]: ai/algorithms/ALGORITHM_SELECTION.md "Phase 13 blocked algorithm-selection record"
[6]: ai/models/EVALUATION_PLAN.md "Phase 13 evaluation plan"
[7]: ai/models/BIAS_FAIRNESS_PLAN.md "Phase 13 bias/fairness plan"
[8]: ai/safety/CLINICAL_SAFETY_PLAN.md "Phase 13 clinical safety plan"
[9]: docs/AI_SRS_TRACEABILITY.md "Phase 13 SRS traceability"
[10]: docs/PHASE13_NEXT_PHASE_REQUIREMENTS.md "Requirements before the next model phase"
[11]: docs/PHASE12_IMPLEMENTATION_BLOCKER.md "Phase 12 blocker carried into Phase 13"
[12]: docs/phase10-integration-audit.md "Phase 10 safe deferred AI decision"
